• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型人类免疫缺陷病毒对中和抗体的免疫逃逸:多种途径的证据

Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways.

作者信息

Watkins B A, Reitz M S, Wilson C A, Aldrich K, Davis A E, Robert-Guroff M

机构信息

Laboratory of Tumor Cell Biology, National Cancer Institute, Bethesda, Maryland 20892.

出版信息

J Virol. 1993 Dec;67(12):7493-500. doi: 10.1128/JVI.67.12.7493-7500.1993.

DOI:10.1128/JVI.67.12.7493-7500.1993
PMID:7693973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC238215/
Abstract

Sera from many HIV-1-infected individuals contain broadly reactive, specific neutralizing antibodies. Despite their broad reactivity, variant viruses, resistant to neutralization, can be selected in vitro in the presence of such antisera. We have previously shown that neutralization resistance of an escape mutant with an amino acid substitution in the transmembrane protein (A582T) occurs because of alteration of a conformational epitope that is recognized by neutralizing antibodies directed against the CD4 binding site. In this report we demonstrate that immune escape via a single-amino-acid substitution (A281V) within a conserved region of the envelope glycoprotein gp120 confers neutralization resistance against a broadly reactive neutralizing antiserum from a seropositive individual. We show this alteration affects V3 and additional regions unrelated to V3 or the CD4 binding site. Together with previous studies on escape mutants selected in vitro, our findings suggest that immune-selective pressure can arise by multiple pathways.

摘要

许多感染HIV-1的个体血清中含有广泛反应性的特异性中和抗体。尽管这些抗体具有广泛反应性,但在存在此类抗血清的情况下,仍可在体外筛选出对中和作用具有抗性的变异病毒。我们之前已经表明,跨膜蛋白中发生氨基酸取代(A582T)的逃逸突变体产生中和抗性,是因为针对CD4结合位点的中和抗体所识别的构象表位发生了改变。在本报告中,我们证明包膜糖蛋白gp120保守区域内的单氨基酸取代(A281V)导致的免疫逃逸赋予了对一名血清阳性个体的广泛反应性中和抗血清的中和抗性。我们表明这种改变影响V3以及与V3或CD4结合位点无关的其他区域。结合之前关于体外筛选出的逃逸突变体的研究,我们的发现表明免疫选择压力可通过多种途径产生。

相似文献

1
Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways.1型人类免疫缺陷病毒对中和抗体的免疫逃逸:多种途径的证据
J Virol. 1993 Dec;67(12):7493-500. doi: 10.1128/JVI.67.12.7493-7500.1993.
2
Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites.1型人类免疫缺陷病毒对天然抗血清中和作用的抗性是通过单个氨基酸取代发生的,这些取代会导致多个位点的抗体结合发生变化。
J Virol. 1996 Dec;70(12):8431-7. doi: 10.1128/JVI.70.12.8431-8437.1996.
3
Neutralization epitopes of the HIV-1 primary isolate DH012.HIV-1原始分离株DH012的中和表位
Vaccine. 2003 Jul 4;21(23):3301-6. doi: 10.1016/s0264-410x(03)00218-4.
4
Resistance to neutralization by broadly reactive antibodies to the human immunodeficiency virus type 1 gp120 glycoprotein conferred by a gp41 amino acid change.由gp41氨基酸变化导致的对人免疫缺陷病毒1型gp120糖蛋白广泛反应性抗体中和作用的抗性。
J Virol. 1994 Feb;68(2):674-80. doi: 10.1128/JVI.68.2.674-680.1994.
5
Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120.用可溶性CD4-gp120复合物进行免疫接种,优先诱导针对gp120构象依赖性表位的中和抗1型人类免疫缺陷病毒抗体。
J Virol. 1994 Sep;68(9):5854-62. doi: 10.1128/JVI.68.9.5854-5862.1994.
6
Resistance of a human serum-selected human immunodeficiency virus type 1 escape mutant to neutralization by CD4 binding site monoclonal antibodies is conferred by a single amino acid change in gp120.人血清筛选出的1型人类免疫缺陷病毒逃逸突变体对CD4结合位点单克隆抗体中和作用的抗性,是由gp120中的单个氨基酸变化所导致的。
J Virol. 1993 Sep;67(9):5216-25. doi: 10.1128/JVI.67.9.5216-5225.1993.
7
Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans.针对1型人类免疫缺陷病毒gp120糖蛋白上不连续或构象敏感表位的抗体在受感染人类血清中高度普遍。
J Virol. 1993 Feb;67(2):863-75. doi: 10.1128/JVI.67.2.863-875.1993.
8
Analysis of the cross-reactive anti-gp120 antibody population in human immunodeficiency virus-infected asymptomatic individuals.人类免疫缺陷病毒感染无症状个体中交叉反应性抗 gp120 抗体群体的分析。
J Virol. 1993 Feb;67(2):953-60. doi: 10.1128/JVI.67.2.953-960.1993.
9
A predominant group-specific neutralizing epitope of human immunodeficiency virus type 1 maps to residues 342 to 511 of the envelope glycoprotein gp120.人类免疫缺陷病毒1型主要的群特异性中和表位定位于包膜糖蛋白gp120的342至511位氨基酸残基处。
J Virol. 1991 Nov;65(11):5983-90. doi: 10.1128/JVI.65.11.5983-5990.1991.
10
Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120.与I型人类免疫缺陷病毒gp120的CD4结合位点和V3结构域结合的配体之间的协同相互作用。
Virology. 1992 Dec;191(2):732-42. doi: 10.1016/0042-6822(92)90249-o.

引用本文的文献

1
SARS-CoV-2 Infection of Rhesus Macaques Treated Early with Human COVID-19 Convalescent Plasma.感染 SARS-CoV-2 的恒河猴经早期人 COVID-19 恢复期血浆治疗。
Microbiol Spectr. 2021 Dec 22;9(3):e0139721. doi: 10.1128/Spectrum.01397-21. Epub 2021 Nov 24.
2
High-Resolution Sequencing of Viral Populations during Early Simian Immunodeficiency Virus Infection Reveals Evolutionary Strategies for Rapid Escape from Emerging Env-Specific Antibody Responses.早期猿猴免疫缺陷病毒感染期间病毒群体的高分辨率测序揭示了快速逃避新出现的Env特异性抗体反应的进化策略。
J Virol. 2018 Mar 14;92(7). doi: 10.1128/JVI.01574-17. Print 2018 Apr 1.
3
HIV-1 envelope sequence-based diversity measures for identifying recent infections.基于HIV-1包膜序列的多样性测量用于识别近期感染。
PLoS One. 2017 Dec 28;12(12):e0189999. doi: 10.1371/journal.pone.0189999. eCollection 2017.
4
Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus.性传播模式之间选择瓶颈的差异影响HIV-1原始病毒的基因组成。
PLoS Pathog. 2016 May 10;12(5):e1005619. doi: 10.1371/journal.ppat.1005619. eCollection 2016 May.
5
HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+ T Cell Responses.与人类白细胞抗原II类相关的HIV多态性预测CD4+T细胞反应逃逸。
PLoS Pathog. 2015 Aug 24;11(8):e1005111. doi: 10.1371/journal.ppat.1005111. eCollection 2015 Aug.
6
HIV-1 envelope glycoprotein resistance to monoclonal antibody 2G12 is subject-specific and context-dependent in macaques and humans.在猕猴和人类中,HIV-1包膜糖蛋白对单克隆抗体2G12的抗性具有个体特异性且依赖于具体情况。
PLoS One. 2013 Sep 9;8(9):e75277. doi: 10.1371/journal.pone.0075277. eCollection 2013.
7
Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linked.抗体的强效人类免疫缺陷病毒中和活性和补体溶解活性并非必然相关。
J Virol. 2008 Apr;82(8):3834-42. doi: 10.1128/JVI.02569-07. Epub 2008 Jan 30.
8
Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors.作为进入介质、疫苗免疫原和抑制剂靶点的HIV包膜糖蛋白的结构与功能
Adv Pharmacol. 2007;55:33-97. doi: 10.1016/S1054-3589(07)55002-7.
9
Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma.植入1型人类免疫缺陷病毒(HIV-1)特异性表位的猿猴免疫缺陷病毒:复制、中和作用及对HIV-1阳性血浆的检测
J Virol. 2006 Mar;80(6):3030-41. doi: 10.1128/JVI.80.6.3030-3041.2006.
10
Increased sensitivity to CD4 binding site-directed neutralization following in vitro propagation on primary lymphocytes of a neutralization-resistant human immunodeficiency virus IIIB strain isolated from an accidentally infected laboratory worker.从一名意外感染的实验室工作人员分离出的中和抗性人类免疫缺陷病毒IIIB株在原代淋巴细胞上进行体外增殖后,对CD4结合位点定向中和的敏感性增加。
J Virol. 2004 Jun;78(11):5651-7. doi: 10.1128/JVI.78.11.5651-5657.2004.

本文引用的文献

1
An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.人类免疫缺陷病毒1型跨膜蛋白中的一个免疫选择点突变(HXB2-Env:Ala 582(-->Thr))降低了针对CD4结合位点的单克隆抗体对病毒的中和作用。
Virology. 1993 Sep;196(1):332-7. doi: 10.1006/viro.1993.1484.
2
Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability.包膜糖蛋白gp120的结构构象影响人类免疫缺陷病毒1型感染性、宿主范围及形成合胞体能力的证据。
J Virol. 1993 Sep;67(9):5635-9. doi: 10.1128/JVI.67.9.5635-5639.1993.
3
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding.对人免疫缺陷病毒1型(HIV-1)gp120与CD4结合后暴露的保守中和表位的鉴定。
J Virol. 1993 Jul;67(7):3978-88. doi: 10.1128/JVI.67.7.3978-3988.1993.
4
Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape.人类免疫缺陷病毒1型感染期间的中和抗体反应:类型和组特异性以及病毒逃逸
J Gen Virol. 1993 May;74 ( Pt 5):855-63. doi: 10.1099/0022-1317-74-5-855.
5
Human immunodeficiency virus (HIV) type 1 strain MN neutralizing antibody in HIV-infected children: correlation with clinical status and prognostic value.1型人类免疫缺陷病毒(HIV)MN株中和抗体在HIV感染儿童中的情况:与临床状态的相关性及预后价值
J Infect Dis. 1993 Mar;167(3):538-46. doi: 10.1093/infdis/167.3.538.
6
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.从艾滋病患者和有患艾滋病风险的人群中频繁检测和分离出细胞病变逆转录病毒(HTLV-III)。
Science. 1984 May 4;224(4648):500-3. doi: 10.1126/science.6200936.
7
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.从艾滋病患者和艾滋病前期患者中检测、分离并持续生产细胞病变逆转录病毒(HTLV-III)。
Science. 1984 May 4;224(4648):497-500. doi: 10.1126/science.6200935.
8
Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome.获得性免疫缺陷综合征中人类T细胞白血病(嗜淋巴细胞)病毒III型的分子特征
Science. 1984 Dec 7;226(4679):1165-71. doi: 10.1126/science.6095449.
9
In vitro generation of an HTLV-III variant by neutralizing antibody.通过中和抗体在体外产生HTLV-III变体。
J Immunol. 1986 Nov 15;137(10):3306-9.
10
Dideoxy sequencing method using denatured plasmid templates.使用变性质粒模板的双脱氧测序法。
Anal Biochem. 1986 Feb 1;152(2):232-8. doi: 10.1016/0003-2697(86)90403-3.